KPV 10mg

KPV is a small tripeptide (Lys‑Pro‑Val) derived from the C‑terminal fragment of α‑MSH and is studied in experimental systems for its anti‑inflammatory activity. Research focuses on how this minimal peptide behaves in controlled environments such as cell cultures and animal models.

In these laboratory settings, researchers have observed that KPV can modulate NF‑κB‑related signalling, reduce pro‑inflammatory cytokine activity, and interact with pathways involved in gut and skin inflammation. These findings come entirely from preclinical experiments and do not imply any clinical effects.